In Vitro Diagnostics (IVD) include reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. The reagents, instruments and systems are used in the collection, preparation, and examination of specimens taken from the human body. This includes Cardiac Disease, Hematological Disorders, Hormonal Disorders, Metabolic Disorder, Infectious Disease, IVD Analyzers, Oncology and Reproductive Health Diagnostics. Diabetes Assays are tests used to measure various biomarkers related to diabetes that help in diagnosing the condition, monitoring its progression, and assessing the effectiveness of treatment. GlobalData uses proprietary data and analytics to provide a comprehensive report on the diabetes assays devices market, including market shares of different players within Italy. Buy the latest report here.
In 2023, GlobalData’s Market Model methodology determined that the leading player in the diabetes assays market in Italy was Abbott Laboratories followed by Siemens Healthineers, Danaher, F. Hoffmann-La Roche, EKF Diagnostics, Bio-Rad Laboratories, Quidelortho, Sinocare, Tosoh and DiaSorin.
The Diabetes Assays comprises C-Peptide Assay, Glycated Hemoglobin (HbA1c) Lab Assay, Glycated Hemoglobin (HbA1c) Point of care (POC) Assay, Insulin Assay, and Fasting Glucose Assay.
The value of the diabetes assays devices market within Italy was expected to be over $20m in 2023.
For the latest complete market share analysis of diabetes assays device market in Italy, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.